Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Well also provide tips and treatment options for side effect management
Not even a question
Currently a research peptide, it is hoped in the future it could offer a therapeutic treatment for the following: Hypoactive Sexual Desire Disorder PT-141 peptide stimulates sexual desire and arousal in individuals with hypoactive sexual desire disorder (HSDD) through its unique mechanism of action
Alternative Names: Tesamorelin (GHRH Analog), CJC-1295 (Modified GRF 1-29), Ipamorelin (Synthetic Pentapeptide) Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Studies and Research Data Potential Pituitary Signaling Pathways Research on Tesamorelin and CJC-1295 suggests that they may bind to GHRH receptors, potentially initiating intracellular signaling cascades involving cyclic adenosine monophosphate (cAMP) and protein kinase pathways
![One Piece Legacy of the Master Booster Box [OP12]](https://www.stompinggroundstcg.com/cdn/shop/files/OP-12_Legacy_of_the_Master_One_Piece_Booster_Box_Display_600x.webp?v=1753403797)
![Tirzepatide vs. Semaglutide: Which GLP-1 Better Preserves Muscle? [SURMOUNT-5 Data]](https://www.clinicalnutritioncenter.com/wp-content/uploads/2026/04/research-image-2026-04-10-1024x559.jpg)
